In patients with spontaneous intracerebral hemorrhage
|
|
- Marilyn Mosley
- 5 years ago
- Views:
Transcription
1 Incident Cerebral Microbleeds in a Cohort of Intracerebral Hemorrhage Marta Pasquini, MD; Marije R. Benedictus, MSc; Grégoire Boulouis, MD; Costanza Rossi, PhD; Nelly Dequatre-Ponchelle, MD; Charlotte Cordonnier, PhD Background and Purpose We aimed to identify prognostic and associated factors of incident cerebral microbleeds (CMBs) in intracerebral hemorrhage (ICH) survivors. Methods Observational prospective cohort of 168 ICH survivors who underwent 1.5T magnetic resonance imaging at ICH onset and during follow-up (median scan interval, 3.4; interquartile range, ) years. We used logistic regression adjusted for age, sex, and scan interval. Analyses were stratified according to the index ICH location (58 lobar ICH, 103 nonlobar ICH, excluding patients with multiple or unclassifiable ICH). Results Eighty-nine (53%) patients had CMBs at ICH onset, and 80 (48%) exhibited incident CMBs during follow-up. Predictors of incident CMBs at ICH onset were 1 CMBs (adjusted odds ratio [aor], 2.27; 95% confidence interval [CI], ), old radiological macrohemorrhage (aor, 6.78; 95% CI, ), and CMBs in mixed location (aor, 3.73; 95% CI, ). When stratifying by ICH location, incident CMBs were associated in nonlobar ICH with incident lacunes (aor, 2.86; 95% CI, ) and with the use of antiplatelet agents (aor, 2.89; 95% CI, ). In lobar ICH, incident CMBs were associated with incident radiological macrohemorrhage (aor, 9.76; 95% CI, ). Conclusions Prognostic and associated factors of incident CMBs differed according to the index ICH location. Whereas in lobar ICH, incident CMBs were associated with hemorrhagic biomarkers, in nonlobar ICH, ischemic burden also increased. CMBs may be interesting biomarkers to monitor in randomized trials on restarting antithrombotic drugs after ICH. (Stroke. 2016;47: DOI: /STROKEAHA ) Key Words: antithrombotic drugs cerebral hemorrhage cerebral microbleeds cohort studies magnetic resonance imaging In patients with spontaneous intracerebral hemorrhage (ICH), cerebral microbleeds (CMBs) are highly prevalent. 1 Their presence and number have been associated with a higher risk of recurrent ICH among ICH survivors 2,3 and with a higher risk of ICH among ischemic stroke survivors. 4 Furthermore, some evidence suggests that CMBs may increase the risk of antithrombotic-associated ICH: a systematic review of 1460 patients with ICH found that CMBs were almost twice as common at the time of ICH in people using warfarin versus those not using any type of antithrombotic drug. 5 This has led to consider CMBs as markers of bleeding-prone vasculopathies 6 and to avoid the use of antithrombotic drugs in patients with CMBs. 7 However, whether CMBs really increase the risk of antithrombotic-associated ICH remains uncertain. Before using CMBs as a surrogate marker of recurrent ICH, and avoiding therapies of proven benefit, prognostic and associated factors of incident CMBs should be better understood. Indeed, although incident CMBs have been associated with a higher risk of recurrent ICH in lobar ICH, 2 little is known about nonlobar ICH, and the influence of antithrombotic drugs may differ in these 2 groups of patients. Therefore, we studied prognostic factors of incident CMBs in an observational prospective ICH cohort with longterm follow-up, stratifying the analysis according to the index ICH location. Patients and Methods We included patients from The Prognosis of Intracerebral Hemorrhage (PITCH) cohort study, 8 an ongoing observational study that prospectively recruited consecutive adults admitted with ICH to the emergency department of Lille University Hospital from November 2004 to April 2009 in Lille, France (n=560). We excluded patients with purely intraventricular or extra-axial intracranial hemorrhage, with ICH attributable to a secondary cause of ICH (intracranial vascular malformation, head trauma, tumor or hemorrhagic transformation within a cerebral infarct, or congenital coagulopathies), and with no reliable data on ongoing treatment at presentation, discharge, or during follow-up. For this study, our inclusion criteria were (1) survival Received October 15, 2015; final revision received December 21, 2015; accepted December 24, From the Univ. Lille, Inserm, CHU Lille, U 1171, Degenerative and vascular cognitive disorders, Lille, France, (M.P., G.B., C.R., N.D.-P., C.C.); Department of Neurology, Groupement des Hôpitaux de l Institut Catholique de Lille, Saint Philibert Hospital, Lille, France (M.P.); and Alzheimer Center and, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands (M.R.B.). Correspondence to Charlotte Cordonnier, PhD, Univ. Lille, Inserm, CHU Lille, U 1171, Degenerative and Vascular Cognitive Disorders, F Lille, France. charlotte.cordonnier@chru-lille.fr 2016 American Heart Association, Inc. Stroke is available at DOI: /STROKEAHA
2 690 Stroke March 2016 for at least 6 months after ICH and (2) at least 2 brain magnetic resonance imaging (MRI). At baseline, we prospectively collected demographic characteristics, vascular risk factors (arterial hypertension, diabetes mellitus, smoking, excessive alcohol consumption, and atrial fibrillation), and past medical history (ischemic stroke or transient ischemic attack, ICH, ischemic heart disease, and dementia). Definitions were previously published. 8 We recorded antithrombotic drugs use according to type (antiplatelet agents, oral anticoagulants, or both) and assessed the use of these drugs at presentation and hospital discharge. Follow-up visit was scheduled for all survivors (first at 6 months, then every year). At each follow-up visit, we recorded the use of antithrombotic drugs, blood pressure lowering drugs, and statins. Blood pressure was measured manually at each visit. Brain MRI was performed at presentation and during follow-up unless contraindicated. Main variables of interest were available for all patients. The design of the PITCH cohort is in line with the Strengthening the Reporting of Observational Studies in Epidemiology statement. 9 Radiological Assessment All MRIs were rated by a study investigator with expertise in stroke and training in neuroradiology, blinded to clinical data and time points. For the present analysis, we considered the first MRI performed after the index ICH (median [interquartile range {IQR}] delay, 7 [4 14] days after ICH) and the MRI performed at the latest visit or the closest to time of death (follow-up MRI, median [IQR] scan interval, 3.4 [ ] years). At each time point, we performed an identical MRI protocol with identical acquisition parameters using a 1.5 Tesla scanner (GE Healthcare, Milwaukee, WI) including at least T1-weighted, Fluid-Attenuated Inversion Recovery, and T2* Gradient-Echo weighted sequences (echo time, 22.8 ms; repetition time, 700 ms; flip angle, 25 ; field of view, 250 mm; matrix ; slice thickness, 5 mm; and interslice gap, 1.5 mm). On each MRI, we recorded ICH location, classified as (1) lobar when exclusively involving the cerebral hemispheres superficial to the deep gray matter structures; (2) nonlobar when exclusively involving lenticular or caudate nuclei, thalamus, internal or external capsule, brain stem, or cerebellum; (3) unclassifiable when the origin of the bleeding could not be reliably identified, (4) multiple if there were >1 ICH at presentation. We assessed global cortical atrophy using a 4-point rating scale 10 (dichotomized: absent [0 1] or present [2 3]) and white matter hyperintensities using the Fazekas scale, 11 a 4-point rating scale (dichotomized: absent [0 1] or present [2 3]). The term lacune was used to describe scars of lacunar infarctions and referred to deep, subcortical, or pontine ovoid lesions (3 15 mm) with cerebrospinal fluid like signal with or without a hyperintense fluid-attenuated Inversion Recovery border 12 (pragmatic consensus was obtained to differentiate lacunes from dilated perivascular spaces in problematic cases). Lacunes were scored as present or absent. The presence, number, and location (lobar versus nonlobar) of old radiological macrohemorrhages (>10 mm) other than the index ICH were also recorded. CMBs were defined as round foci of hypointense signal, 10 mm in brain parenchyma on T2* Gradient-Echo weighted images and rated using the Brain Observer MicroBleed Scale. 13 CMBs presence was defined as the presence of at least 1 CMB, and their location was classified as strictly lobar (when involving the cortex, the gray white matter junction, and the subcortical white matter), nonlobar (when involving the basal ganglia, internal capsule, or posterior fossa), or mixed when involving both lobar and nonlobar structures. Incident CMBs were defined as a difference of 1 in the number of CMBs between the 2 MRIs. The same definition was used for incident lacunes. We found less CMBs at follow-up when compared with the MRI at ICH onset in 15 patients. These patients were added to the group of no incident CMBs. 14 We defined global cortical atrophy and white matter hyperintensities progression as any change in category from MRI at ICH onset to follow-up MRI. We recorded the appearance of new radiological macrohemorrhage. Statistical Analysis To determine whether survivors at 6 months with follow-up MRI differed from those for whom follow-up MRI was not available, we compared the main baseline characteristics and initial clinical severity between those 2 groups, using χ 2 test for categorical variables and Mann Whitney U test for continuous variables (data not shown). We investigated characteristics associated with the incidence of CMBs during follow-up using bivariate logistic regression analysis, then adjusted for age, sex, and scan interval. Then, we stratified our analyses according to the index ICH location (lobar/nonlobar) because of the potential influence of the underlying vasculopathy (mostly cerebral amyloid angiopathy in lobar ICH and mostly deep perforating vasculopathy in nonlobar ICH). We performed statistical analyses with the SPSS 22.0 (windows). Ethics The study protocol was considered as observational by the internal review board of the Lille University Hospital. No written consent was requested. The database was declared to the ad hoc commission protecting personal data. Results From the original PITCH cohort, 264 patients were alive 6 months after ICH onset. Eighty-two patients were excluded because they could not undergo MRI (Figure 1). Of the remaining 182 patients, 168 had at least 2 MRIs of good quality and were included in our study. The excluded patients were more likely to be older, to have a history of previous ICH, and to be demented at the time of ICH onset when compared with patients in the follow-up group (data not shown). Baseline severity of neurological deficit was similar in the 2 groups of patients. Baseline Characteristics Among 168 patients (median age, 64 years; IQR, 53 76), 89 patients (53%) had at least 1 CMBs at baseline (median number of CMBs in patients with at least 1 CMBs [IQR], 4 [ ]), of whom 18 (20%) had strictly lobar CMBs, 25 (28%) had strictly nonlobar CMBs, and 46 (52%) had CMBs in mixed location. The number of CMBs in the whole brain area ranged from 0 to 53. The anatomic distribution and number of CMBs were similar in patients with lobar and nonlobar ICH (P=0.83 and P=0.36, respectively; Table 1). Incidence of CMBs Incident CMBs appeared in 80 patients (48%; 95% confidence interval [CI], 40% 55%) in a median delay of 3.4 (IQR, Figure 1. Flowchart of the study population. ICH indicates intracerebral hemorrhage; and MRI, magnetic resonance imaging.
3 Pasquini et al Incident Microbleeds After ICH ) years (including 29 patients without CMBs at ICH onset), with a total number of 285 new CMBs, leading to an incidence rate of 14.2 per 100 person-years. The rate of increase in the number of CMBs was 0.5 lesions per year in the overall cohort, a number which increased to 0.7 lesions per year in patients with CMBs at baseline. Among patients with lobar ICH (n=58), 26 patients (45%; 95% CI, 32 58) had incident CMBs, of whom 8 (31%; 95% CI, 12 50) had strictly lobar incident CMBs, 11 (42%; 95% CI, 22 63) strictly nonlobar CMBs, and 7 (27%; 95% CI, 9 45) had incident CMBs in mixed location. Among patients with nonlobar ICH (n=103), 50 (48%; 95% CI, 39 58) had incident CMBs, of whom 10 (20%; 95% CI, 8 31) had strictly lobar incident CMBs, 24 (48%; 95% CI, 34 62) had strictly nonlobar CMBs, and 16 (32%; 95% CI, 19 45) had incident CMBs in mixed location. Prognostic Factors of Incident CMBs The results of the bivariate and multivariable analyses comparing patients with and without incident CMBs are summarized in Table 1. Patients with CMBs at ICH onset had a 2.5-fold increased risk of developing incident CMBs during the followup period when compared with patients without CMBs at ICH onset (adjusted odds ratio [aor], 2.27; 95% CI, ). This was especially true for patients with multiple CMBs at baseline (Figure 2). Patients with incident CMBs were more likely to exhibit CMBs in mixed location (aor, 3.73; 95% CI, ) and old radiological macrohemorrhages (aor, 6.78; 95% CI, ) at ICH onset. Although the use of antiplatelet agents during follow-up was associated with incident CMBs in bivariate analysis (OR, 2.11; 95% CI, ), this result failed to reach significance (aor, 1.80; 95% CI, ) when adjusted with age, sex, and scan interval. When stratifying patients according to the index ICH location (lobar and nonlobar), some differences emerged (Tables 2 and 3). The influence of antiplatelet agent use during followup for incident CMBs was significant in patients with nonlobar ICH (aor, 2.89; 95% CI, ), but not in patients with lobar ICH (aor, 0.89; 95% CI, ). Of note, the proportion of antiplatelet agent use was similar in lobar and nonlobar ICH (31% and 32%, respectively; P=0.89). In patients with nonlobar ICH, incident CMBs were associated with incidence of new lacunes (aor, 2.86; 95% CI, ), whereas in patients with lobar ICH, incident CMBs were associated with the appearance of new radiological Table 1. Factors Associated With the Incidence of CMBs in ICH Patients No Incident CMBs (n=88) Incident CMBs (n=80) OR aor (Age, Sex, and Scan Interval) Past medical history History of arterial hypertension 55 (62) 50 (62) 1.00 ( ) 0.96 ( ) ICH 3 (3) 4 (5) 1.49 ( ) 1.60 ( ) Dementia 9 (10) 4 (5) 0.47 ( ) 0.43 ( ) Ischemic stroke or TIA 8 (9) 12 (15) 1.76 ( ) 1.78 ( ) Median (IQR) SBP during follow-up 130 ( ) 133 ( ) 0.99 ( ) 1.00 ( ) Median (IQR) DBP during follow-up 70 (60 75) 72 (69 77) 1.02 ( ) 1.02 ( ) Medication during follow-up Statins 37 (42) 41 (51) 1.45 ( ) 1.10 ( ) Antiplatelets 22 (25)* 33 (41)* 2.11 ( )* 1.80 ( ) Oral anticoagulants 13 (15) 12 (15) 1.02 ( ) 0.81 ( ) Radiological characteristics WMH severity at ICH onset 1.87 ( )* 2.13 ( )* (57)* 33 (41)* (43)* 47 (59)* WMH progression 14 (16) 14 (17) 1.11 ( ) 0.87 ( ) GCA severity at ICH onset 0.93 ( ) 0.98 ( ) (56) 46 (57) (44) 34 (43) GCA progression 15 (17)* 24 (30)* 2.09 ( )* 1.61 ( ) Presence of lacunes at ICH onset 28 (32) 37 (46) 1.84 ( ) 2.02 ( )* Incident lacunes on follow-up MRI 18 (20) 21 (26) 1.38 ( ) 1.40 ( ) Presence of CMBs at ICH onset 38 (43)* 51 (64)* 2.31 ( )* 2.27 ( )* Presence of old macrohemorrhage at ICH onset 8 (9)* 30 (37)* 6.00 ( )* 6.78 ( )* New macrohemorrhage on follow-up MRI 3 (3) 9 (11) 3.64 ( ) 3.56 ( ) Results from bivariate and multivariate analyses. Values in the second and third columns represent number of patients (%) unless specified. aor indicates adjusted odds ratio; CMBs, cerebral microbleeds; DBP, diastolic blood pressure; GCA, global cortical atrophy; ICH, intracerebral hemorrhage; IQR, interquartile range; MRI, magnetic resonance imaging; OR, odds ratio; SBP, systolic blood pressure; TIA, transient ischemic attack; and WMH, white matter hyperintensities.
4 692 Stroke March 2016 Figure 2. Proportion of patients with incident cerebral microbleeds (CMBs) according to number of CMBs at intracerebral hemorrhage (ICH) onset. macrohemorrhage (aor, 9.76; 95% CI, ), which occurred only in lobar location. Discussion In our longitudinal observational ICH cohort, 48% (95% CI, 40 55) of patients exhibited incident CMBs over a 3.4-year interval between MRIs. Prognostic and associated factors of incident CMBs differed according to the index ICH location. In nonlobar ICH, incident CMBs were associated with incident lacunes (aor, 2.86; 95% CI, ) and with the use of antiplatelet agents during follow-up (aor, 2.89; 95% CI, ), whereas in lobar ICH, incident CMBs were associated with incident radiological macrohemorrhages (aor, 9.76; 95% CI, ). These results suggest an implication of the nature of the underlying vessel disease that eventually led to the index ICH. The strength of our study was to provide long-term MRI follow-up data in a large cohort of ICH survivors. Data were collected prospectively, with rigorous information on treatment and standardized predefined MRI analyses. Although our cohort is hospital based, the baseline characteristics of our population were similar to those of a population-based registry, consistent with recommendations on observational studies, 9 providing reassurance on the external validity of our results. Because of the longitudinal, observational design of this study, the time point of last follow-up MRI was not standardized. A possible limitation of the study is that selective dropout may have influenced our results. People who participated were younger and healthier than Table 2. Factors Associated With the Incidence of CMBs in the 103 Patients With Nonlobar ICH No Incident CMBs (n=53) Incident CMBs (n=50) OR aor (Age, Sex, and Scan Interval) Past medical history History of arterial hypertension 35 (66) 33 (66) 1.00 ( ) 0.91 ( ) ICH 1 (2) 2 (4) 2.17 ( ) 1.60 ( ) Dementia 3 (6) 3 (6) 1.09 ( ) 0.96 ( ) Ischemic stroke or TIA 3 (6)* 10 (20)* 4.17 ( )* 3.74 ( ) Median (IQR) SBP during follow-up 130 ( ) 133 ( ) 0.99 ( ) 0.99 ( ) Median (IQR) DBP during follow-up 79 (72 85) 78 (74 85) 1.01 ( ) 1.01 ( ) Medication during follow-up Statins 19 (36)* 30 (60)* 2.68 ( )* 1.92 ( ) Antiplatelets 10 (19)* 23 (46)* 3.66 ( )* 2.89 ( )* Oral anticoagulants 6 (11) 9 (18) 1.72 ( ) 1.71 ( ) Radiological characteristics WMH severity at ICH onset 1.65 ( ) 1.67 ( ) (58) 23 (46) (42) 27 (54) WMH progression 9 (17) 8 (16) 0.91 ( ) 0.61 ( ) GCA severity at ICH onset 1.19 ( ) 0.71 ( ) (62) 29 (58) (38) 21 (42) GCA progression 7 (13)* 16 (32)* 3.09 ( )* 2.17 ( ) Presence of lacunes at ICH onset 20 (38) 27 (54) 1.94 ( ) 2.17 ( ) Incident lacunes on follow-up MRI 8 (15)* 16 (32)* 2.65 ( )* 2.86 ( )* Presence of CMBs at ICH onset 21 (40) 29 (58) 2.10 ( ) 1.88 ( ) Presence of old macrohemorrhage at ICH onset 4 (7)* 18 (36)* 6.89 ( )* 6.96 ( )* New macrohemorrhage on follow-up MRI 2 (4) 2 (4) 1.08 ( ) 1.24 ( ) Results from bivariate and multivariable analyses. Values in the second and third columns represent number of patients (%) unless specified. aor indicates adjusted odds ratio; CMBs, cerebral microbleeds; DBP, diastolic blood pressure; GCA, global cortical atrophy; ICH, intracerebral hemorrhage; IQR, interquartile range; MRI, magnetic resonance imaging; OR, odds ratio; SBP, systolic blood pressure; TIA, transient ischemic attack; and WMH, white matter hyperintensities.
5 Pasquini et al Incident Microbleeds After ICH 693 Table 3. Factors Associated With the Incidence of CMBs in the 58 Patients With Lobar ICH No Incident CMBs (n=32) those who were ineligible for a follow-up MRI scan. In this case, we may have slightly underestimated the true incidence of CMBs in our cohort. In our subgroup analyses on lobar and nonlobar ICH, we dealt with smaller numbers of patients; therefore, our results should be interpreted with caution. Finally, this study was observational, so conclusions cannot be drawn on the causal relationship between antiplatelet drugs and incident CMBs. In our cohort of ICH survivors, the incidence of new CMBs reached 48% over 3.4 years of follow-up when compared with 18% over 2 years in patients with lacunar strokes. 15 In the general population, cumulative incidences of CMBs ranged from 6.9% over a 4-year period 16 to 10% over a 3-year period, 14 whereas in a memory clinic population, an incidence of 12% was reported (follow-up interval, 1.9 years). 17 The higher incidence in our study probably reflects the manifest small-vessel pathology present in all our ICH patients. In small series of patients with primary ICH, with a shorter follow-up, similar incidence rates (30% 50%) were reported. 2,3,18,19 Higher blood pressure levels were considered as prognostic factors of incident CMBs in ischemic stroke survivors 15,20 and in a cohort of essential hypertensive patients. 21 In our ICH cohort, Incident CMBs (n=26) OR aor (Age, Sex, and Scan Interval) Past medical history History of arterial hypertension 19 (60) 15 (58) 0.93 ( ) 0.87 ( ) ICH 2 (6) 1 (4) 0.60 ( ) 0.69 ( ) Dementia 6 (19) 1 (4) 0.17 ( ) 0.14 ( ) Ischemic stroke or TIA 5 (16) 2 (8) 0.45 ( ) 0.46 ( ) Median (IQR) SBP during follow-up 127 ( ) 134 ( ) 1.01 ( ) 1.02 ( ) Median (IQR) DBP during follow-up 73 (67 75) 75 (70 85) 1.04 ( ) 1.05 ( ) Medication during follow-up Statins 16 (50) 10 (38) 0.62 ( ) 0.49 ( ) Antiplatelets 10 (31) 8 (30) 0.98 ( ) 0.89 ( ) Oral anticoagulants 7 (21) 3 (11) 0.47 ( ) 0.35 ( ) Radiological characteristics WMH severity at ICH onset 2.25 ( ) 2.82 ( ) (50) 8 (31) (50) 18 (69) WMH progression 5 (16) 6 (23) 1.62 ( ) 1.53 ( ) GCA severity at ICH onset 1.70 ( ) 1.86 ( ) (41) 14 (54) (59) 12 (46) GCA progression 8 (25) 7 (27) 1.10 ( ) 1.08 ( ) Presence of lacunes at ICH onset 8 (25) 9 (35) 1.59 ( ) 1.61 ( ) Incident lacunes on follow-up MRI 10 (31) 3 (11) 0.29 ( ) 0.28 ( ) Presence of CMBs at ICH onset 16 (50) 19 (73) 2.71 ( ) 2.70 ( ) Presence of old macrohemorrhage at ICH onset 3 (9)* 11 (42)* 7.09 ( )* 9.36 ( )* New macrohemorrhage on follow-up MRI 1 (3)* 6 (23)* 9.30 ( )* 9.76 ( )* Results from bivariate and multivariable analyses. Values in the second and third columns represent number of patients (%) unless specified. aor indicates adjusted odds ratio; CMBs, cerebral microbleeds; DBP, diastolic blood pressure; GCA, global cortical atrophy; ICH, intracerebral hemorrhage; IQR, interquartile range; MRI, magnetic resonance imaging; OR, odds ratio; SBP, systolic blood pressure; TIA, transient ischemic attack; and WMH, white matter hyperintensities. we did not report such a prognostic factor. Our larger study sample 15,20 with higher incidence of CMBs 21 could explain this difference. Moreover, we used mean values of blood pressure measured during each follow-up visit, which may better reflect blood pressure control during follow-up, whereas other studies mainly focused on blood pressure levels at baseline. Because of the regular follow-up by a stroke neurologist, we achieved a relatively good blood pressure control, which could also explain the lack of association. The presence and number of CMBs, and the presence of old radiological macrohemorrhages at ICH onset, predicted incident CMBs. This is consistent with results from previous studies. 2,14,15,19,21 Interestingly, prognostic and associated factors differed according to the ICH location, suggesting an impact of the nature of the underlying vessel disease. In lobar ICH, incident CMBs were associated with incident new radiological macrohemorrhage, which confirms previous result 2 and suggests that incident CMBs are markers of a bleedingprone vasculopathy when associated with lobar ICH, although the small numbers of events must lead to caution. By contrast, in nonlobar ICH, incident CMBs were associated with incident lacunes, suggesting that ischemic and hemorrhagic
6 694 Stroke March 2016 burden both increased. In the overall cohort, we found a trend for the association with antiplatelet use during follow-up and incident CMBs, which was significant only in nonlobar ICH. However, no inference can be made about a causal relationship because incident CMBs may reflect the evolution of the underlying vessel disease requiring antiplatelet agents. In conclusion, incident CMBs frequently appeared during follow-up. Prognostic and associated factors of incident CMBs differed according to the index ICH location. Although in patients with lobar ICH, incident CMBs were associated with hemorrhagic-prone biomarkers, in patients with nonlobar ICH, the meaning of CMBs progression is not as straightforward because ischemic burden also increased. Therefore, CMBs may be interesting surrogate biomarkers to monitor in future randomized clinical trial addressing the question of restarting, or not, antithrombotic drugs after ICH. Sources of Funding M.R. Benedictus was supported by a fellowship of Alzheimer Nederland (WE ). Disclosures Drs Rossi and Dequatre-Ponchelle were investigators in clinical trials (Pfizer, Pierre Fabre). Dr Cordonnier was investigator in clinical trials (Pfizer, Pierre Fabre, and Astra-Zeneca). She serves on scientific boards for Bayer. She is a member of the Institut Universitaire de France. There was no personal funding for any of the authors. The other authors report no conflicts. References 1. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007;130(pt 8): doi: / brain/awl Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35: doi: /01. STR e. 3. Jeon SB, Kang DW, Cho AH, Lee EM, Choi CG, Kwon SU, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage. J Neurol. 2007;254: doi: /s Fan YH, Zhang L, Lam WW, Mok VC, Wong KS. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Stroke. 2003;34: doi: /01. STR Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL, Sorimachi T, et al; Edinburgh Stroke Study Group. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41: doi: /STROKEAHA Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al; Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8: doi: /S (09) Brown MM. Identification and management of difficult stroke and TIA syndromes. J Neurol Neurosurg Psychiatry. 2001;70(suppl 1):I17 I Cordonnier C, Rutgers MP, Dumont F, Pasquini M, Lejeune JP, Garrigue D, et al. Intra-cerebral haemorrhages: are there any differences in baseline characteristics and intra-hospital mortality between hospitaland population-based registries? J Neurol. 2009;256: doi: / s von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370: doi: /S (07)61602-X. 10. Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36: Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer s dementia and normal aging. AJR Am J Roentgenol. 1987;149: doi: /ajr Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al; STandards for ReportIng Vascular changes on neuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12: doi: /S (13) Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL, et al. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke. 2009;40: doi: /STROKEAHA Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke. 2011;42: doi: / STROKEAHA Klarenbeek P, van Oostenbrugge RJ, Rouhl RP, Knottnerus IL, Staals J. Higher ambulatory blood pressure relates to new cerebral microbleeds: 2-year follow-up study in lacunar stroke patients. Stroke. 2013;44: doi: /STROKEAHA Akoudad S, Darweesh SK, Leening MJ, Koudstaal PJ, Hofman A, van der Lugt A, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population. Stroke. 2014;45: doi: /STROKEAHA Goos JD, Henneman WJ, Sluimer JD, Vrenken H, Sluimer IC, Barkhof F, et al. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology. 2010;74: doi: / WNL.0b013e3181e396ea. 18. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology. 2006;67: doi: /01. wnl Mackey J, Wing JJ, Norato G, Sobotka I, Menon RS, Burgess RE, et al. High rate of microbleed formation following primary intracerebral hemorrhage. Int J Stroke. 2015;10: Gregoire SM, Brown MM, Kallis C, Jäger HR, Yousry TA, Werring DJ. MRI detection of new microbleeds in patients with ischemic stroke: fiveyear cohort follow-up study. Stroke. 2010;41: doi: / STROKEAHA van Dooren M, Staals J, de Leeuw PW, Kroon AA, Henskens LH, van Oostenbrugge RJ. Progression of brain microbleeds in essential hypertensive patients: a 2-year follow-up study. Am J Hypertens. 2014;27: doi: /ajh/hpu032.
Cerebral microbleeds (CMBs) are old (micro) hemorrhages
Higher Ambulatory Blood Pressure Relates to New Cerebral Microbleeds 2-Year Follow-Up Study in Lacunar Stroke Patients Pim Klarenbeek, MD; Robert J. van Oostenbrugge, MD, PhD; Rob P.W. Rouhl, MD, PhD;
More informationINTRACEREBRAL HAEMORRHAGE:
INTRACEREBRAL HAEMORRHAGE: WHAT IS THE CAUSE? Prof. Charlotte Cordonnier Head, Department of neurology & stroke centre Director, Lille haemorrhagic stroke research program Lille University Hospital France
More informationA common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds
Cerebral microbleeds and intracranial haemorrhage risk in patients with atrial fibrillation after acute ischaemic stroke or transient ischaemic attack: multicentre observational cohort study D. Wilson,
More informationCerebral microbleeds (CMBs) are detected on T2*-
Cerebral Microbleeds and Recurrent Stroke Risk Systematic Review and Meta-Analysis of Prospective Ischemic Stroke and Transient Ischemic Attack Cohorts Andreas Charidimou, MSc; Puneet Kakar, MD; Zoe Fox,
More informationAsymptomatic lacunar infarcts, white matter lesions, cerebral
Ambulatory Blood Pressure in Patients With Lacunar Stroke Association With Total MRI Burden of Cerebral Small Vessel Disease Pim Klarenbeek, MD; Robert J. van Oostenbrugge, MD, PhD; Rob P.W. Rouhl, MD,
More informationMagnetic resonance imaging (MRI) has the potential to
Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage Gudrun Roob, MD; Anita Lechner, MD; Reinhold Schmidt, MD; Erich Flooh, MSc; Hans-Peter Hartung, MD; Franz Fazekas,
More informationStarting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective
Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective Cathy Sila MD George M Humphrey II Professor and Vice Chair of Neurology Director, Comprehensive Stroke Center
More informationDifferent Impacts of Blood Pressure Variability on the Progression of Cerebral Microbleeds and White Matter Lesions
Different Impacts of Blood Pressure Variability on the Progression of Cerebral Microbleeds and White Matter Lesions Wenhong Liu, MD; Ran Liu, MD; Wei Sun, MD; Qing Peng, MD; Weiwei Zhang, MD; En Xu, MD;
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Stroke subtype, vascular risk factors and total MRI brain small vessel disease burden Citation for published version: Staals, J, Makin, S, Doubal, F, Dennis, M & Wardlaw, J
More informationCerebral small vessel disease
Cerebral small vessel disease What is it? What are the clinical syndromes? How do we diagnose it? What is the pathophysiology? New insights from genetics? Possible therapies? Small Vessel disease Changes
More informationdoi: /brain/awq246 Brain 2010: 133; What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?
doi:10.1093/brain/awq246 Brain 2010: 133; 3281 3289 3281 BRAIN A JOURNAL OF NEUROLOGY What are the causes of pre-existing dementia in patients with intracerebral haemorrhages? Charlotte Cordonnier, 1 Didier
More informationZhenyu Jia, MD,* Wasif Mohammed, MD,* Yiru Qiu, MD, Xunning Hong, MD,* and Haibin Shi, MD, PhD*
Hypertension Increases the Risk of Cerebral Microbleed in the Territory of Posterior Cerebral Artery: A Study of the Association of Microbleeds Categorized on a Basis of Vascular Territories and Cardiovascular
More informationGiuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia
Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia Charidimou et al, 2012 Pathogenesis of spontaneous and anticoagulationassociated
More informationMBs present as homogeneous round lesions with signalintensity
ORIGINAL RESEARCH Y. Sueda H. Naka T. Ohtsuki T. Kono S. Aoki T. Ohshita E. Nomura S. Wakabayashi T. Kohriyama M. Matsumoto Positional Relationship between Recurrent Intracerebral Hemorrhage/Lacunar Infarction
More informationP oirier et al classified lacunar infarcts into three types:
423 PAPER Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes S-H Lee, H-J Bae, S-B Ko, H Kim, B-W Yoon, J-K Roh... See end of article for authors affiliations...
More informationPRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans
PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans Inclusion Criteria Clinical syndrome Patients must have clinical evidence
More informationBrain tissue and white matter lesion volume analysis in diabetes mellitus type 2
Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 C. Jongen J. van der Grond L.J. Kappelle G.J. Biessels M.A. Viergever J.P.W. Pluim On behalf of the Utrecht Diabetic Encephalopathy
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationSupplementary Online Content
Supplementary Online Content Hooshmand B, Magialasche F, Kalpouzos G, et al. Association of vitamin B, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults: a longitudinal
More informationCase 9511 Hypertensive microangiopathy
Case 9511 Hypertensive microangiopathy Schepers S, Barthels C Section: Neuroradiology Published: 2011, Nov. 3 Patient: 67 year(s), male Authors' Institution Department of Radiology, Jessa ziekenhuis campus
More informationMagnetic resonance imaging in patients with atrial fibrillation before left atrial appendage closure after brain hemorrhage
Magnetic resonance imaging in patients with atrial fibrillation before left atrial appenda closure after brain Background: Brain MRI may be helpful for selecting patients at higher risk of further bleeding
More informationTotal small vessel disease score and risk of recurrent stroke Validation in 2 large cohorts
Total small vessel disease score and risk of recurrent stroke Validation in 2 large cohorts Kui Kai Lau, MRCP Linxin Li, MD, DPhil Ursula Schulz, DPhil Michela Simoni, MD, DPhil Koon Ho Chan, MD, PhD Shu
More informationM. Edip Gurol, MD, MSc Stroke Service/Neurology, Massachusetts General Hospital, Harvard Medical School
High Risk of Thromboembolism and ICH: Problems with Medical Management M. Edip Gurol, MD, MSc Stroke Service/Neurology, Massachusetts General Hospital, Harvard Medical School Disclosures Funding from NIH
More informationInvestigators meeting. Thursday 7 June 2012
Investigators meeting Thursday 7 June 2012 Future plans Substudies Transient neurological episodes Genetics Biomarkers Retina changes Cognitive follow-up study Thrombolysis ICH Transient focal neurological
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationThe Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging
The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline
More informationThrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE
Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE ESUS Progression of haematoma Anticoagulation Large ICH
More informationCADASIL: structural MR imaging changes and apolipoprotein E genotype S E V E N
CADASIL: structural MR imaging changes and apolipoprotein E genotype S E V E N CADASIL: structural MR imaging changes and apolipoprotein E genotype R. van den Boom S.A.J. Lesnik Oberstein A.A. van den
More informationGrowing evidence has implicated deposition of -amyloid
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage Steven M. Greenberg, MD, PhD; Jessica A. Eng, BA; MingMing Ning, MD; Eric E. Smith, MD; Jonathan Rosand, MD, MS Background
More informationAdvances in MR imaging technology have led to improved
ORIGINAL RESEARCH R.N.K. Nandigam A. Viswanathan P. Delgado M.E. Skehan E.E. Smith J. Rosand S.M. Greenberg B.C. Dickerson MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted
More informationRestart or stop antithrombotics after intracerebral haemorrhage (ICH)?
Restart or stop antithrombotics after intracerebral haemorrhage (ICH)? Rustam Al-Shahi Salman professor of clinical neurology & honorary consultant neurologist www.rush.ed.ac.uk @BleedingStroke /bleedingstroke
More informationPatients with Alzheimer s disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition 2.4
Patients with Alzheimer s disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition Chapter Abstract Background and Purpose: Microbleeds (MBs) are commonly observed
More informationDistributional Impact of Brain Microbleeds on Global Cognitive Function in Adults Without Neurological Disorder
Distributional Impact of Brain Microbleeds on Global Cognitive Function in Adults Without Neurological Disorder Yusuke Yakushiji, MD, PhD; Tomoyuki Noguchi, MD, PhD; Megumi Hara, MD, PhD; Masashi Nishihara,
More informationThe use of susceptibility-weighted imaging to detect cerebral microbleeds after lacunar infarction
European Review for Medical and Pharmacological Sciences 2017; 21: 3105-3112 The use of susceptibility-weighted imaging to detect cerebral microbleeds after lacunar infarction L. SHAO 1, M. WANG 1, X.-H.
More informationLothian Audit of the Treatment of Cerebral Haemorrhage (LATCH)
1. INTRODUCTION Stroke physicians, emergency department doctors, and neurologists are often unsure about which patients they should refer for neurosurgical intervention. Early neurosurgical evacuation
More informationNew Frontiers in Intracerebral Hemorrhage
New Frontiers in Intracerebral Hemorrhage Ryan Hakimi, DO, MS Director, Neuro ICU Director, Inpatient Neurology Services Greenville Health System Clinical Associate Professor Department of Medicine (Neurology)
More informationCerebral small vessel disease (SVD) related lesions, including
Frontal and Temporal Are Related to Cognitive The Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study Anouk G.W. van Norden, MD; Heleen A.C. van den Berg, BSc; Karlijn
More informationHypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine
Hypertensive Haemorrhagic Stroke Dr Philip Lam Thuon Mine Intracerebral Haemorrhage Primary ICH Spontaneous rupture of small vessels damaged by HBP Basal ganglia, thalamus, pons and cerebellum Amyloid
More informationSilent Cerebral Strokes: Clinical Outcomes and Management
Silent Cerebral Strokes: Clinical Outcomes and Management Nagaendran Kandiah Senior Consultant Neurologist, National Neuroscience Institute, Singapore Clinician Scientist, National Medical Research Council,
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More informationWhite Matter Perivascular Spaces Are Related to Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy
White Matter Perivascular Spaces Are Related to Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy Andreas Charidimou, MD, MSc; Rolf H. Jäger, MD; Andre Peeters, MD; Yves Vandermeeren, PhD;
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationThe Effect of Statin Therapy on Risk of Intracranial Hemorrhage
The Effect of Statin Therapy on Risk of Intracranial Hemorrhage JENNIFER HANIFY, PHARM.D. PGY2 CRITICAL CARE RESIDENT UF HEALTH JACKSONVILLE JANUARY 23 RD 2016 Objectives Review benefits of statin therapy
More informationIschemic strokes are estimated to happen during sleep in
Can Diffusion-Weighted Imaging Fluid-Attenuated Inversion Recovery Mismatch (Positive Diffusion-Weighted Imaging/ Negative Fluid-Attenuated Inversion Recovery) at 3 Tesla Identify Patients With Stroke
More information[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]
2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available
More informationIntroduction. Abstract. Michael Yannes 1, Jennifer V. Frabizzio, MD 1, and Qaisar A. Shah, MD 1 1
Reversal of CT hypodensity after acute ischemic stroke Michael Yannes 1, Jennifer V. Frabizzio, MD 1, and Qaisar A. Shah, MD 1 1 Abington Memorial Hospital in Abington, Pennsylvania Abstract We report
More informationEnlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease
Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease Fergus N. Doubal, MRCP; Alasdair M.J. MacLullich, MRCP; Karen J. Ferguson, PhD; Martin S. Dennis, FRCP; Joanna M. Wardlaw,
More informationYong-Bum Kim, M.D., Kwang-Ho Lee, M.D., Soo-Joo Lee, M.D., Duk-L. Na, M.D., Soo-Jin Cho, M.D., Chin-Sang Chung, M.D., Won-Yong Lee M.D.
Usefulness of Apolipoprotein E 4 and Distribution of Petechial Hemorrhages in Differentiating between Cerebral Amyloid Angiopathy and Hypertensive Intracerebral Hemorrhage Yong-Bum Kim, M.D., Kwang-Ho
More informationMicrobleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke
Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke Guillaume Turc, MD; Asmaa Sallem, MD; Solène Moulin, MD; Marie Tisserand, MD; Alexandre Machet,
More informationCitation for the original published paper (version of record):
http://www.diva-portal.org This is the published version of a paper published in Fluids and Barriers of the CNS. Citation for the original published paper (version of record): Johansson, E., Ambarki, K.,
More informationMinute hemorrhages on gradient-echo MRI can result
Hypertensive Pontine Microhemorrhage Jee-Hyang Jeong, MD; Soo Jin Yoon, MD; Sue J. Kang, MS; Kyung Gyu Choi, MD; Duk L. Na, MD Background and Purpose This study investigated whether the topography of hypertensive
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationORIGINAL ARTICLE. Predictors of Highly Prevalent Brain Ischemia in Intracerebral Hemorrhage
ORIGINAL ARTICLE Predictors of Highly Prevalent Brain Ischemia in Intracerebral Hemorrhage Ravi S. Menon, MD, 1 Richard E. Burgess, MD, PhD, 1 Jeffrey J. Wing, MPH, 2 M. Christopher Gibbons, MD, MPH, 3
More informationPublished December 18, 2014 as /ajnr.A4176
Published December 18, 2014 as 10.3174/ajnr.A4176 ORIGINAL RESEARCH BRAIN Cerebral Microbleeds: Different Prevalence, Topography, and Risk Factors Depending on Dementia Diagnosis The Karolinska Imaging
More informationSmall vessel disease and post stroke cognitive impairment
Small vessel disease and post stroke cognitive impairment Dr Fergus Doubal Stroke Association Clinical Senior Lecturer Consultant Stroke Physician and Geriatrician Royal Infirmary of Edinburgh Outline
More informationHigher ambulatory blood pressure relates to enlarged Virchow-Robin spaces in first-ever lacunar stroke patients
J Neurol (2013) 260:115 121 DOI 10.1007/s00415-012-6598-z ORIGINAL COMMUNICATION Higher ambulatory blood pressure relates to enlarged Virchow-Robin spaces in first-ever lacunar stroke patients Pim Klarenbeek
More informationTopography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort
Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort Sara Shams, MD, PhD; Juha Martola, MD, PhD; Andreas Charidimou, MD, PhD; Mykol
More informationLa gestione dell ictus ischemico o emorragico nel paziente sotto NAO
La gestione dell ictus ischemico o emorragico nel paziente sotto NAO Antonio Carolei e Cindy Tiseo Clinica Neurologica e Stroke Unit Avezzano - Sulmona Università degli Studi dell Aquila Abano Terme, 10
More informationRelationship between lesion patterns of single small infarct and early neurological deterioration in the perforating territory
European Review for Medical and Pharmacological Sciences 2017; 21: 3642-3648 Relationship between lesion patterns of single small infarct and early neurological deterioration in the perforating territory
More informationOn-line Table 1: Dementia diagnoses and related ICD codes for the diagnostic groups a
On-line Table 1: diagnoses and related ICD codes for the diagnostic groups a Diagnosis (N = 1504) ICD Code Patients Scanned with 3T; SWI (%) Subjective cognitive impairment (n 385) Z03.2A, Z03.3, and R41.8A
More informationStroke is the third-leading cause of death and a major
Long-Term Mortality and Recurrent Stroke Risk Among Chinese Stroke Patients With Predominant Intracranial Atherosclerosis Ka Sing Wong, MD; Huan Li, MD Background and Purpose The goal of this study was
More informationSupplementary Online Content
Supplementary Online Content Gregg NM, Kim AE, Gurol ME, et al. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals. JAMA Neurol. Published online July 13, 2015. doi:10.1001/jamaneurol.2015.1359.
More informationControversies in Hemorrhagic Stroke Management. Sarah L. Livesay, DNP, RN, ACNP-BC, ACNS-BC Associate Professor Rush University
Controversies in Hemorrhagic Stroke Management Sarah L. Livesay, DNP, RN, ACNP-BC, ACNS-BC Associate Professor Rush University Disclosures AHA/ASA Outline Blood pressure VTE Coagulopathy Early mobilization
More informationSTRIVE Neuroimaging Standards for Measuring and Reporting Vascular Changes in Neurodegeneration
STRIVE Neuroimaging Standards for Measuring and Reporting Vascular Changes in Neurodegeneration Eric Smith Katthy Taylor Chair in Vascular Dementia Research University of Calgary Dr. Sandra Black Brill
More informationSupratentorial cerebral arteriovenous malformations : a clinical analysis
Original article: Supratentorial cerebral arteriovenous malformations : a clinical analysis Dr. Rajneesh Gour 1, Dr. S. N. Ghosh 2, Dr. Sumit Deb 3 1Dept.Of Surgery,Chirayu Medical College & Research Centre,
More informationSilent Cerebral Microbleeds on T2*-Weighted MRI. Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis
Silent Cerebral Microbleeds on T2*-Weighted MRI Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis Hiroyuki Kato, MD, PhD; Masahiro Izumiyama, MD, PhD; Kimiaki Izumiyama, MD, PhD; Akira
More informationTransient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction
Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology
More informationAtrial fibrillation is a potent risk factor for ischemic
Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants Margaret C. Fang, MD, MPH; Alan S. Go, MD; Yuchiao Chang, PhD; Leila
More informationPrimary Stroke Center Quality & Performance Measures
Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition
More informationCavitation After Acute Symptomatic Lacunar Stroke Depends on Time, Location, and MRI Sequence
Cavitation After Acute Symptomatic Lacunar Stroke Depends on Time, Location, and MRI Sequence Francois Moreau, MD; Shiel Patel, BSc; M. Louis Lauzon, PhD; Cheryl R. McCreary, PhD; Mayank Goyal, MD, FRCPC;
More informationDiabetes mellitus is an accepted independent risk factor for
Lacunar Strokes in Patients With Diabetes Mellitus: Risk Factors, Infarct Location, and Prognosis The Secondary Prevention of Small Subcortical Strokes Study Santiago Palacio, MD; Leslie A. McClure, PhD;
More informationEvolving Concept of Small Vessel Disease through Advanced Brain Imaging.
Evolving Concept of Small Vessel Disease through Advanced Brain Imaging. Norrving, Bo Published in: Journal of Stroke DOI: 10.5853/jos.2015.17.2.94 Published: 2015-01-01 Link to publication Citation for
More informationHemorrhage. Dr. Al Jin Nov. 17, 2015
Hemorrhage Dr. Al Jin Nov. 17, 2015 None Disclosures ICH Management in ER ABCs Treat hypertension What BP target? Reverse warfarin Hemorrhage vs Ischemic Stroke Lowering BP may be harmful in ischemic stroke
More informationStroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012
Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model
More informationPatients presenting with acute stroke while on DOACs
Patients presenting with acute stroke while on DOACs Vemmos Kostas, MD, PhD Stroke Medicine Hellenic Cardiovascular Research Society Conflicts of interest Honoraria and speaker fees from: BAYER, SANOFI,
More informationPatients With Alzheimer Disease With Multiple Microbleeds Relation With Cerebrospinal Fluid Biomarkers and Cognition
Patients With Alzheimer Disease With Multiple Microbleeds Relation With Cerebrospinal Fluid Biomarkers and Cognition Jeroen D.C. Goos, MD; M.I. Kester, MD; Frederik Barkhof, MD, PhD; Martin Klein, PhD;
More informationPatient with vertigo, dizziness and depression
Clinical Case - Test Yourself Neuro/Head and Neck Radiology Patient with vertigo, dizziness and depression Michael Mantatzis, Paraskevi Argyropoulou, Panos Prassopoulos Radiology Department, Democritus
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationSporadic cerebral amyloid angiopathy (CAA) is a common
Spectrum of Transient Focal Neurological Episodes in Cerebral Amyloid Angiopathy Multicentre Magnetic Resonance Imaging Cohort Study and Meta-Analysis Andreas Charidimou, MSc; Andre Peeters, Zoe Fox, PhD;
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Warfarin and the risk of major bleeding events in patients with atrial fibrillation: a population-based study Laurent Azoulay PhD 1,2, Sophie Dell Aniello MSc 1, Teresa
More informationUpdates from 2017 International Stroke Conferences
Updates from 2017 International Stroke Conferences Ravi Menon, MD Swedish Neuroscience Institute May 11, 2017 Seattle, WA 1 Disclosures No relevant financial disclosures Clinical trial involvement: Former
More informationNIH Public Access Author Manuscript Stroke. Author manuscript; available in PMC 2015 January 16.
NIH Public Access Author Manuscript Published in final edited form as: Stroke. 2013 November ; 44(11): 3229 3231. doi:10.1161/strokeaha.113.002814. Sex differences in the use of early do-not-resuscitate
More informationCerebral Microbleeds Are Predictive of Mortality in the Elderly
Cerebral Microbleeds Are Predictive of Mortality in the Elderly Irmhild Altmann-Schneider, MD; Stella Trompet, PhD; Anton J.M. de Craen, PhD; Adriaan C.G.M. van Es, MD; J. Wouter Jukema, MD, PhD; David
More informationPreexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients Pascal P. Gratz, MD*; Marwan El-Koussy, MD*; Kety Hsieh, MD; Sebastian
More informationLongitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset
CLINICAL ARTICLE Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset Shusuke Yamamoto, MD, Satoshi Hori, MD, PhD,
More informationTIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012
Charles Ashton Medical Director TIA AND STROKE Topics/Order of the day 1 What Works? Clinical features of TIA inc the difference between Carotid and Vertebral territories When is a TIA not a TIA TIA management
More informationORIGINAL CONTRIBUTION. How Complex Interactions of Ischemic Brain Infarcts, White Matter Lesions, and Atrophy Relate to Poststroke Dementia
ORIGINAL CONTRIBUTION How Complex Interactions of Ischemic Brain Infarcts, White Matter Lesions, and Atrophy Relate to Poststroke Dementia Tarja Pohjasvaara, MD, PhD; Riitta Mäntylä, MD; Oili Salonen,
More informationChronic kidney disease (CKD), as an important public
Chronic Kidney Disease in Patients With Lacunar Stroke Association With Enlarged Perivascular Spaces and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease Lulu Xiao, MD*; Wenya Lan,
More informationSpeakers. 2015, American Heart Association 1
Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,
More informationSingle Subcortical Infarction and Atherosclerotic Plaques in the Middle Cerebral Artery High-Resolution Magnetic Resonance Imaging Findings
Single Subcortical Infarction and Atherosclerotic Plaques in the Middle Cerebral Artery High-Resolution Magnetic Resonance Imaging Findings Youngshin Yoon, MD; Deok Hee Lee, MD, PhD; Dong-Wha Kang, MD,
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationW hite matter high intensity lesions (WML) on T2
576 PAPER Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis H Yamauchi, H Fukuda, C Oyanagi... See end of article for authors affiliations... Correspondence
More informationSilent Infarction in Patients with First-ever Stroke
221 Silent Infarction in Patients with First-ever Stroke Cheung-Ter Ong 1, Wen-Pin Chen 2, Sheng-Feng Sung 1, Chi-Shun Wu 1, and Yung-Chu Hsu 1 Abstract- Background / Purpose: Silent infarcts (SIs) are
More informationWhite matter perivascular spaces An MRI marker in pathology-proven cerebral amyloid angiopathy?
White matter perivascular spaces An MRI marker in pathology-proven cerebral amyloid angiopathy? Andreas Charidimou, MD, MSc Zane Jaunmuktane, MD Jean-Claude Baron, PhD Matthew Burnell, PhD Pascale Varlet,
More informationBlood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang, Chung-Shiuan Chen, Qi Zhao, Jing Chen for CATIS
More informationEssentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II
14. Ischemia and Infarction II Lacunar infarcts are small deep parenchymal lesions involving the basal ganglia, internal capsule, thalamus, and brainstem. The vascular supply of these areas includes the
More informationDiagnostic improvement from average image in acute ischemic stroke
Diagnostic improvement from average image in acute ischemic stroke N. Magne (1), E.Tollard (1), O. Ozkul- Wermester (2), V. Macaigne (1), J.-N. Dacher (1), E. Gerardin (1) (1) Department of Radiology,
More informationEmergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)
2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates) Summary of Changes I62.9 added to hemorrhagic stroke ICD-10-CM diagnosis code list (table 3) Measure Description Methodology Rationale Measurement
More information